Henar Hevia Pérez, researcher in the area of Genic Therapy and Hepatology at the Applied Medicine Research Centre (CIMA)of the University of Navarra, has discovered the protective role of the methylthioadenosine (MTA) molecule in an in vivo inflammation model. The doctor has recently defended her PhD thesis at the Faculty of Sciences.
According to the biochemist, the inflammatory component is key in the development of many diseases, including those affecting the liver and, therefore, of vital importance in creating new therapeutic strategies aimed at mitigating their effects.
Besides many other functions, the liver plays an essential role in the metabolism of aminoacids, amongst which are metionine, an essential aminoacid and the metabolism of which is altered in hepatic diseases such as cirrhosis and liver cancer. As a result, the focus of the researchers for some time has been the study of the hepatic metabolism of this aminoacid and the pathological consequences of its alteration.
Garazi Andonegi | alfa
New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia
New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
18.08.2017 | Life Sciences
18.08.2017 | Physics and Astronomy
18.08.2017 | Materials Sciences